Skip to main content
. 2016 Sep 8;17(5):329–340. doi: 10.1120/jacmp.v17i5.6291

Table 3.

Significance for each parameter studied between grouped SS, VMAT, and HT (significance identified when p<0.05).

p‐value
SS& VMAT SS & HT VMAT & HT
PTV
Dmax(Gy)
0.957
<0.001
<0.001
Mean dose (Gy) 0.213
<0.001
<0.001
D2cm (%) 0.978 0.168 0.152
CI95%
0.058 0.015
<0.001
CI80%
0.117 0.055
<0.001
CI50%
0.176 0.083 0.003
Cord
Dmax(Gy)
0.017 0.507 0.323
Bronchus
Dmax(Gy)
0.611 0.218 0.742
Esophagus
Dmax(Gy)
0.686 0.993 0.755
Heart
Dmax(Gy)
0.152 0.552 0.552
Trachea
Dmax(Gy)
0.626 0.004 0.020
Total lung MLD (Gy) 0.561 0.005 0.001
V50% (cm3) 0.779 0.369 0.113
V50% (%) 0.756 0.341 0.093
V20% (%) 0.918 0.247 0.119
V10Gy (%) 0.990 0.002 0.002
V5Gy (%) 0.898
<0.001
<0.001
Cont. lung V10Gy (%) 0.778 0.091 0.044
V5Gy (%) 0.204
<0.001
<0.001
Efficiency MLC Motion 0.123 N/A N/A
Monitor Units 0.607 0.516 0.787
Delivery time (min)
<0.001
<0.001
<0.001